AbCellera Biologics Inc
ABCLHealthcare·Biotechnology·Canada·Mid·NASD·Nov 13 • 7:00 AM ET
11.75+0.13 (1.12%)
2026-11-13 13:00 CET
Market cap
$3.84B
Revenue, TTM
67.86 USD m
Net income, TTM
-148.30 USD m
Free cash flow, TTM
-31.35 USD m
EPS diluted, TTM
-0.48
Price
ABCL against its 20, 50 and 200-day averagesPatternshover a marker to name it
21.7% under the 52-week high of 15.02 on 30 Sep 2026. 52-week low 2.75 on 5 Feb 2026. Last 15 sessions, 28.8% high to low
Volume 0.06× normal · the line is the 50-bar volume average
Setup. RS line 92
CANSLIM 3 of 6 — fails: EPS Growth This Year: High (>25%); 52-Week High/Low: 0-10% below High; Institutional Ownership: Over 50%
VCP 5 of 6 — fails: 52-Week High/Low: 0-10% below High
Minervini 3 of 4 — fails: 52-Week High/Low: 0-10% below High
Zanger 1 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 3 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 52-Week High/Low: 0-10% below High
Breakout 1 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50
Growth 1 of 4 — fails: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 0 of 4 — fails: P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 3 of 4 — fails: Float: Under 100M
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 3 of 3
Profile
ABCL52-week range, 73% of the way up
2.7515.02
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Veronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
| Employees | 562 |
|---|---|
| IPO | Dec 11, 2020 |
| Beta | 1.59 |
| ATR, 14d | 0.91 |
| Rel volume | 0.06 |
| Short float | 11.35% |
| Insider own | 21.74% |
| Inst own | 35.28% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | $3.84B |
| Enterprise Value | 3.18B |
| Income | -148.30M |
| Sales | 67.86M |
| Book / share | 3.26 |
| Cash / share | 2.42 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 562 |
| IPO | Dec 11, 2020 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 56.55 |
| Price / book | 3.61 |
| Price / cash | 4.86 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 46.89 |
| Quick Ratio | 12.33 |
| Current Ratio | 12.43 |
| Debt / equity | 0.13 |
| Long-term debt / equity | 0.12 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -0.48 |
|---|---|
| Earnings next year | -0.65 |
| Earnings next quarter | -0.16 |
| Earnings this year | -24.58% |
| Earnings next year | -5.97% |
| Earnings growth, 5 years | -13.11% |
| Past earnings growth | - - |
| Past sales growth | -46.31% -20.27% |
| Earnings vs last year | 16.43% |
| Sales vs last year | 92.10% |
| Earnings vs last quarter | 32.97% |
| Sales vs last quarter | 18.81% |
| Earnings | Nov 09 AMC |
| Surprise | 23.80% 26.41% |
Ownership
| Insiders own | 21.74% |
|---|---|
| Insider trades | 0.09% |
| Institutions own | 35.28% |
| Institution trades | -3.90% |
| Return on assets | -10.39% |
| Return on equity | -14.64% |
| Return on capital | -12.46% |
| Gross Margin | 49.93% |
| Operating margin | -297.97% |
| Profit Margin | -218.54% |
| 20-day average | -2.83% |
| 50-day average | -4.80% |
| 200-day average | 62.33% |
Technical
| Shares out | 326.33M |
|---|---|
| Shares floating | 255.61M |
| Short / float | 11.35% |
| Short ratio | 5.70 |
| Short interest | 29.02M |
| 52-week high | 15.02 -21.7% |
| 52-week low | 2.75 +328.1% |
| Volatility | 8.04% 8.05% |
| Average range | 0.91 |
| Strength index | 47.06 |
| Market sensitivity | 1.59 |
| Relative volume | 0.06 |
| Avg Volume | 5.09M |
| Volume | 15,526 |
Performance
| Perf Week | -1.09% |
|---|---|
| Perf Month | -7.33% |
| Perf Quarter | 4.91% |
| Perf Half Y | 187.29% |
| Perf YTD | 243.57% |
| Perf Year | 224.59% |
| Perf 3Y | 195.23% |
| Perf 5Y | -21.77% |
| Perf 10Y | - |
| Recommendation | 1.14 |
| Target Price | 18.00 |
| Prev Close | 11.62 |
| Price | 11.75 |
| Change % | 1.12% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Oct 12, 2026 | Initiated | UBS | Buy | $18 | +53.2% |
| Sep 29, 2026 | Initiated | JP Morgan | Overweight | $17 | +44.7% |
| Sep 24, 2026 | Initiated | Goldman | Neutral | $13 | +10.6% |
| Jul 07, 2026 | Upgrade | The Benchmark Company | Hold → Buy | $11 | -6.4% |
| May 05, 2026 | Initiated | Cantor Fitzgerald | Overweight | $7 | -40.4% |
| Nov 07, 2025 | Downgrade | Leerink Partners | Outperform → Market Perform | $4 | -66.0% |
| Jul 07, 2025 | Resumed | Leerink Partners | Outperform | $5 | -57.4% |
| Aug 20, 2024 | Downgrade | The Benchmark Company | Buy → Hold | ||
| Feb 22, 2024 | Upgrade | The Benchmark Company | Hold → Buy | $9 | -23.4% |
| Dec 05, 2023 | Initiated | KeyBanc Capital Markets | Overweight | $6 | -48.9% |
Peers
Mkt capInsider trading
1 filings| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Thermopylae Holdings Ltd. | 10% Owner | Nov 12 '26 | Buy | 11.54 | 60,565 | 698,920 | 56,194,662 | Nov 12 01:15 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| IBB | iShares Biotechnology ETF | AUM: 11.39B |
| IDNA | iShares Genomics Immunology and Healthcare ETF | AUM: 352.11M |
| SPDW | State Street SPDR Portfolio Developed World ex-US ETF | AUM: 41.93B |
| FDT | First Trust Developed Markets ex-US AlphaDEX Fund | AUM: 1.37B |
| ONEQ | Fidelity Nasdaq Composite Index ETF | AUM: 10.51B |
| AVUS | Avantis U.S. Equity ETF | AUM: 14.85B |
| BBC | Virtus Biotech Clinical Trials ETF | AUM: 31.61M |
| AVSC | Avantis U.S Small Cap Equity ETF | AUM: 3.33B |
| PDN | Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF | AUM: 341.85M |
| IBBQ | Invesco Nasdaq Biotechnology ETF | AUM: 130.85M |
News
latest 14 of 200- AbCellera Tops Estimates, But ABCL635's Breakout Phase 2 Data And A $900 Million War Chest Are The Real Story (Earnings Whispers) +5.22%
- AbCellera Reports Q3 2026 Business Results (Business Wire)
- AbCellera Heads Into Results With Stock Doubled And ABCL635 Phase 2 Data Taking Center Stage (Earnings Whispers) -9.37% +9.53%
- What Could Go Wrong With Recursion Pharmaceuticals Stock? (Trefis) -6.31%
- AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting (Business Wire)
- AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026 (Business Wire)
- AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment (PR Newswire)
- Why Did IOVA, ABCL, CRWD Stocks Surge To 52-Week Highs Today? (Stocktwits) +6.47%
- AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026 (Business Wire) +9.08%
- AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026 (Business Wire)
- AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants (Business Wire) +5.94%
- AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (Business Wire) +6.10%
- Why Did ABCL, REPL, ABNB Stocks Hit 52-Week Highs Today? (Stocktwits) +34.78%
- Hot-Flash Drug Trial Result Sends AbCellera Up as Much as 41% (Bloomberg)
Quarterly earnings
2026Q3 EPS -0.130 beat -0.171, from -0.190 a year earlier. Sales 10.64 beat 8.42, from 8.96 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-09 16:30 | -0.130 | -0.171 | -0.130 | 10.64 | 8.42 | EPS -23.8% · sales +26.4% | vs 2025Q3, year-ago quarter · EPS -31.6% · sales +18.8% | 9 EPS · 11 sales | Open -1.88% vs SPY -0.63%. Close -0.32% vs SPY -0.37% |
| 2026Q2ended 2026-06-30 | 2026-08-05 16:30 | -0.180 | -0.164 | -0.181 | 4.05 | 7.85 | EPS +9.8% · sales -48.4% | vs 2025Q2, year-ago quarter · EPS +50.0% · sales -76.3% | 5 EPS · 8 sales | Open -2.20% vs SPY +0.05%. Close +10.30% vs SPY -0.16% |
| 2026Q1ended 2026-03-31 | 2026-05-11 16:30 | -0.140 | -0.171 | -0.142 | 8.32 | 5.41 | EPS -18.3% · sales +53.6% | vs 2025Q1, year-ago quarter · EPS -6.7% · sales +96.3% | 7 | Open -9.33% vs SPY -0.33%. Close -5.71% vs SPY -0.15% |
| 2025Q4ended 2025-12-31 | 2026-02-24 16:30 | -0.030 | -0.134 | -0.030 | 44.90 | 6.67 | EPS -77.6% · sales +572.9% | vs 2024Q4, year-ago quarter · EPS -75.0% · sales +780.4% | 5 EPS · 6 sales | Open +4.35% vs SPY +0.41%. Close -0.93% vs SPY +0.84% |
| 2025Q3ended 2025-09-30 | 2025-11-06 16:30 | -0.190 | -0.139 | -0.191 | 8.96 | 6.33 | EPS +36.9% · sales +41.4% | vs 2024Q3, year-ago quarter · EPS +11.8% · sales +37.6% | 8 EPS · 9 sales | Open -16.11% vs SPY -0.36%. Close -13.69% vs SPY +0.10% |
| 2025Q2ended 2025-06-30 | 2025-08-07 16:30 | -0.120 | -0.134 | -0.116 | 17.08 | 6.07 | EPS -10.6% · sales +181.3% | vs 2024Q2, year-ago quarter · EPS -7.7% · sales +133.3% | 8 EPS · 9 sales | Open +13.68% vs SPY +0.29%. Close +0.24% vs SPY +0.78% |
| 2025Q1ended 2025-03-31 | 2025-05-08 16:30 | -0.150 | -0.136 | -0.153 | 4.24 | 7.24 | EPS +10.2% · sales -41.5% | vs 2024Q1, year-ago quarter · EPS +7.1% · sales -57.5% | 6 EPS · 8 sales | Open +2.49% vs SPY +0.25%. Close +1.00% vs SPY -0.13% |
| 2024Q4ended 2024-12-31 | 2025-02-27 16:30 | -0.120 | -0.133 | -0.116 | 5.10 | 7.58 | EPS -10.0% · sales -32.7% | vs 2023Q4, year-ago quarter · EPS -25.0% · sales -44.6% | 9 EPS · 10 sales | Open -6.85% vs SPY +0.09%. Close -11.47% vs SPY +1.56% |
| 2024Q3ended 2024-09-30 | 2024-11-05 08:30 | -0.170 | -0.124 | -0.173 | 6.51 | 7.68 | EPS +36.7% · sales -15.3% | vs 2023Q3, year-ago quarter · EPS +70.0% · sales -1.4% | 9 EPS · 10 sales | Open -13.49% vs SPY +0.16%. Close -5.88% vs SPY +1.21% |
| 2024Q2ended 2024-06-30 | 2024-08-06 16:30 | -0.130 | -0.120 | -0.126 | 7.32 | 10.12 | EPS +8.3% · sales -27.6% | vs 2023Q2, year-ago quarter · EPS +18.2% · sales -27.2% | 9 EPS · 10 sales | Open -3.51% vs SPY +1.21%. Close -7.72% vs SPY -0.67% |
| 2024Q1ended 2024-03-31 | 2024-05-07 16:30 | -0.140 | -0.126 | -0.139 | 9.95 | 10.73 | EPS +11.6% · sales -7.2% | vs 2023Q1, year-ago quarter · EPS 0.0% · sales -18.4% | 9 EPS · 10 sales | Open 0.00% vs SPY -0.36%. Close -4.95% vs SPY +0.01% |
| 2023Q4ended 2023-12-31 | 2024-02-20 16:30 | -0.160 | -0.115 | -0.163 | 9.20 | 8.89 | EPS +39.3% · sales +3.4% | vs 2022Q4, year-ago quarter · EPS +61.5% · sales -57.2% | 9 EPS · 10 sales | Open -1.13% vs SPY -0.27%. Close -9.42% vs SPY +0.09% |
| 2023Q3ended 2023-09-30 | 2023-11-02 16:30 | -0.100 | -0.121 | -0.099 | 6.60 | 11.48 | EPS -17.4% · sales -42.5% | vs 2022Q3, year-ago quarter · EPS -225.0% · sales -93.5% | 9 | - |
| 2023Q2ended 2023-06-30 | 2023-08-03 16:30 | -0.110 | -0.134 | -0.106 | 10.06 | 12.38 | EPS -18.1% · sales -18.7% | vs 2022Q2, year-ago quarter · EPS +450.0% · sales -78.1% | 7 | - |
| 2023Q1ended 2023-03-31 | 2023-05-04 16:30 | -0.140 | -0.125 | -0.139 | 12.19 | 12.11 | EPS +12.0% · sales +0.7% | vs 2022Q1, year-ago quarter · EPS -125.9% · sales -96.1% | 7 | - |
| 2022Q4ended 2022-12-31 | 2023-02-21 16:30 | -0.099 | 0.010 | -0.104 | 21.48 | 50.80 | EPS -1121.6% · sales -57.7% | vs 2021Q4, year-ago quarter · EPS -152.2% · sales -84.6% | 9 | - |
Annual earnings
2025FY EPS -0.490 beat -0.580, from -0.550 a year earlier. Sales 75.13 beat 36.30, from 28.83 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | -0.668 | - | - | 117.51 | - |
| 2029FYestimate | - | -0.772 | - | - | 40.64 | - |
| 2028FYestimate | - | -0.709 | - | - | 35.40 | - |
| 2027FYestimate | - | -0.647 | - | - | 33.63 | - |
| 2026FYestimate | - | -0.611 | - | - | 29.76 | - |
| 2025FY | -0.490 | -0.580 | -0.500 | 75.13 | 36.30 | - |
| 2024FY | -0.550 | -0.587 | -0.553 | 28.83 | 31.58 | - |
| 2023FY | -0.510 | -0.460 | -0.506 | 38.03 | 38.13 | - |
| 2022FY | 0.500 | 0.668 | 0.504 | 485.42 | 519.16 | 20.26 |
| 2021FY | 0.480 | 0.524 | 0.482 | 375.2 | 354.36 | 29.79 |
| 2020FY | 0.430 | 0.598 | 0.441 | 233.13 | 212.9 | 93.58 |
Quarterly results
2026Q3 revenue 10.64, from 8.96 a year earlier. Operating margin -501.03%, from -851.34% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E -0.61 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-10 | -0.61 | -5.4% |
| 2026Q4 | E | per share | 2026-11-10 | -0.16 | +2.8% |
| 2026FY | R | per share | 2026-11-10 | -0.61 | -5.4% |
| 2026Q4 | R | per share | 2026-11-10 | -0.16 | +2.8% |
| 2026FY | S | per share | 2026-11-10 | 29.76 | -11.2% |
| 2026Q4 | S | per share | 2026-11-10 | 7.28 | -42.8% |
| 2026Q3 | E | per share | 2026-10-29 | -0.17 | +1.3% |
| 2026Q3 | R | per share | 2026-10-29 | -0.17 | +1.3% |
| 2026Q3 | S | per share | 2026-10-29 | 8.41 | 0.0% |
| 2026Q2 | R | per share | 2026-08-03 | -0.16 | 0.0% |
| 2026Q2 | S | per share | 2026-08-03 | 7.85 | 0.0% |
| 2026Q2 | E | per share | 2026-07-26 | -0.14 | +21.7% |
| 2026Q1 | E | per share | 2026-05-11 | -0.17 | 0.0% |
| 2026Q1 | S | per share | 2026-05-11 | 5.86 | 0.0% |
| 2026Q1 | R | per share | 2026-02-28 | -0.22 | +5.8% |
| 2025FY | E | per share | 2026-02-11 | -0.58 | -5.3% |
| 2025Q4 | E | per share | 2026-02-11 | -0.13 | -9.6% |
| 2025FY | S | per share | 2026-02-11 | 36.30 | +0.6% |
| 2025Q4 | S | per share | 2026-02-11 | 6.67 | +6.2% |
| 2025FY | R | per share | 2026-02-03 | -0.66 | 0.0% |
| 2025Q4 | R | per share | 2026-02-03 | -0.19 | 0.0% |
| 2025Q3 | E | per share | 2025-10-25 | -0.14 | 0.0% |
| 2025Q3 | S | per share | 2025-10-25 | 6.33 | 0.0% |
| 2025Q3 | R | per share | 2025-10-08 | -0.18 | 0.0% |
| 2025Q2 | E | per share | 2025-08-04 | -0.13 | 0.0% |
| 2025Q2 | S | per share | 2025-08-04 | 6.07 | 0.0% |
| 2025Q2 | R | per share | 2025-07-25 | -0.16 | +4.2% |
| 2025Q1 | S | per share | 2025-04-30 | 7.24 | +0.3% |
| 2025Q1 | E | per share | 2025-02-28 | -0.14 | +7.4% |
| 2025Q1 | R | per share | 2025-02-28 | -0.16 | -21.7% |
| 2024FY | E | per share | 2025-01-26 | -0.59 | 0.0% |
| 2024FY | S | per share | 2025-01-26 | 31.58 | 0.0% |
| 2024Q4 | E | per share | 2025-01-19 | -0.13 | 0.0% |
| 2024FY | R | per share | 2025-01-19 | -0.60 | 0.0% |
| 2024Q4 | R | per share | 2025-01-19 | -0.17 | 0.0% |
| 2024Q4 | S | per share | 2025-01-19 | 7.58 | 0.0% |
| 2024Q3 | E | per share | 2024-11-04 | -0.11 | 0.0% |
| 2024Q3 | S | per share | 2024-11-04 | 8.01 | 0.0% |
| 2024Q3 | R | per share | 2024-10-21 | -0.16 | 0.0% |
| 2024Q2 | S | per share | 2024-08-03 | 10.12 | 0.0% |
| 2024Q2 | E | per share | 2024-07-22 | -0.12 | 0.0% |
| 2024Q2 | R | per share | 2024-07-22 | -0.16 | 0.0% |
| 2024Q1 | E | per share | 2024-05-06 | -0.13 | 0.0% |
| 2024Q1 | R | per share | 2024-05-06 | -0.18 | 0.0% |
| 2024Q1 | S | per share | 2024-05-06 | 10.73 | 0.0% |
| 2023FY | R | per share | 2024-01-24 | -0.50 | 0.0% |
| 2023FY | S | per share | 2024-01-24 | 38.13 | 0.0% |
| 2023FY | E | per share | 2024-01-17 | -0.46 | 0.0% |
Estimate history
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | 0.002 | -0.014 | 0.441 | 0.482 | 0.504 | -0.506 | -0.553 | -0.49 | -0.4817 | - |
| Sales USD millions | 9 | 12 | 233 | 375 | 485 | 38 | 29 | 75 | 68 | - |
| Shares million shares | 154 | 154 | 269 | 283 | 287 | 291 | 296 | 301 | - | 326 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.173 | -0.116 | -0.153 | -0.116 | -0.191 | -0.03 | -0.142 | -0.181 | -0.128 |
| Sales USD millions | 7 | 5 | 4 | 17 | 9 | 45 | 8 | 4 | 11 |
| Shares million shares | 295 | 296 | 298 | 299 | 299 | 301 | 304 | 306 | 326 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 67.86 | 75.13+160.6% | 28.83-24.2% | 38.02-92.2% | 485.42+29.4% | 375.20+60.9% | 233.16+1908.3% | 11.61+31.5% | 8.83 |
| Cost of Goods Sold Incl. D&A | 33.98 | 28.82-70.3% | 97.00+214.0% | 30.89 | - | - | - | - | - |
| Gross Profit | 33.88 | 46.31 | -68.17-1056.1% | 7.13 | - | - | - | - | - |
| Selling, General and Administrative Excl. Other | 236.08 | 263.41+6.8% | 246.60+0.9% | 244.34+44.3% | 169.38+56.8% | 108.02+141.6% | 44.71+216.6% | 14.12+63.0% | 8.66 |
| Research and Development | 186.28 | 186.83+11.7% | 167.26-4.8% | 175.66+62.8% | 107.88+73.8% | 62.06+111.2% | 29.39+190.7% | 10.11+74.3% | 5.80 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -202.19 | -217.10 | -314.77 | -237.21-183.8% | 282.95+13.2% | 249.93+36.4% | 183.17 | -4.12 | -0.75 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | - | 5.23-19.7% | 6.51+3000.0% | 0.210.0% | 0.21 |
| Unusual Expense | -0.80 | -0.80 | -0.80-138.1% | 2.10+23.5% | 1.70 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -170.81 | -177.60 | -200.40 | -174.03-172.8% | 239.10+9.1% | 219.15+38.9% | 157.83 | -2.21-812.9% | 0.31 |
| Income Taxes | -22.52 | -31.18 | -37.54 | -27.63-134.3% | 80.58+22.7% | 65.69+68.8% | 38.92 | 0.00 | 0.00 |
| Consolidated Net Income | -148.30 | -146.41 | -162.86 | -146.40-192.4% | 158.52+3.3% | 153.46+29.0% | 118.92 | -2.21-812.9% | 0.31 |
| Net Income From Continuing Operations | -148.30 | -146.41 | -162.86 | -146.40-192.4% | 158.52+3.3% | 153.46+29.0% | 118.92 | -2.21-812.9% | 0.31 |
| Net Income | -148.30 | -146.41 | -162.86 | -146.40-192.4% | 158.52+3.3% | 153.46+29.0% | 118.92 | -2.21-812.9% | 0.31 |
| EPS (Recurring) per share | -0.47 | -0.49 | -0.56 | -0.50-198.0% | 0.51+6.3% | 0.48+9.1% | 0.44 | -0.01 | 0.00 |
| EPS (Basic, Before Extraordinaries) per share | -0.48 | -0.49 | -0.55 | -0.51-191.1% | 0.560.0% | 0.56+27.3% | 0.44 | -0.01 | 0.00 |
| EPS (Diluted) per share | -0.48 | -0.49 | -0.55 | -0.51-202.0% | 0.50+4.2% | 0.48+9.1% | 0.44 | -0.01 | 0.00 |
| EBITDA | -168.22 | -188.28 | -217.77 | -206.31-165.3% | 316.05+18.3% | 267.18+41.8% | 188.44 | -2.51-1576.5% | 0.17 |
| Non-Operating Income (Expense) | 30.58 | 38.71-65.9% | 113.57+74.0% | 65.28 | -42.15 | -25.55 | -18.83-988.2% | 2.12+66.9% | 1.27 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 38.61 | 44.08-17.4% | 53.39+5.3% | 50.71+29.7% | 39.09+73.6% | 22.52+643.2% | 3.03+260.7% | 0.84+35.5% | 0.62 |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | - | - | - | - | 11.58 | 25.49 | - | - | - |
| Price To Sales Ratio ratio | 68.38 | 13.60 | 29.91 | 43.42 | 6.57 | 12.13 | 46.51 | - | - |
| Gross Margin % | 49.93 | 61.64 | -236.42 | 18.75 | - | - | - | - | - |
| Operating Margin % | -297.97 | -288.98 | -1,091.69 | -623.82 | 58.29 | 66.61 | 78.56 | -35.46 | -8.52 |
| Net Margin % | -218.54 | -194.88 | -564.83 | -385.00 | 32.66 | 40.90 | 51.00 | -19.04 | 3.50 |
| Shares Outstanding million shares | 326.33 | 300.60+1.6% | 295.76+1.7% | 290.82+1.4% | 286.85+1.3% | 283.26+5.1% | 269.50+74.9% | 154.090.0% | 154.09 |
| Market Capitalization | 3,795.30 | 3,795.30+338.6% | 865.42-47.8% | 1,656.87-42.8% | 2,898.19-28.0% | 4,026.61-62.3% | 10,686.34-2.1% | 10,914.72 | - |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 10.64+18.8% | 4.05-76.3% | 8.31+96.0% | 44.85+788.1% | 8.96+37.6% | 17.08+133.3% | 4.24-57.4% | 5.05-45.0% |
| Cost of Goods Sold Incl. D&A | 8.62+19.1% | 8.78+24.4% | 8.66+31.0% | 7.92-43.0% | 7.24-81.1% | 7.06-81.4% | 6.61-2.4% | 13.90+52.6% |
| Gross Profit | 2.02+17.4% | -4.73-147.2% | -0.34 | 36.93 | 1.72 | 10.03 | -2.37-174.3% | -8.85-12742.9% |
| Selling, General and Administrative Excl. Other | 55.34-29.1% | 58.04-2.6% | 57.18-5.2% | 65.52+2.5% | 78.00+26.1% | 59.61-5.0% | 60.29+3.8% | 63.90-3.4% |
| Research and Development | 43.54-20.9% | 45.99+17.3% | 46.66+9.8% | 50.09+8.7% | 55.03+34.3% | 39.21-4.2% | 42.50+8.2% | 46.08-5.2% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -53.31 | -62.78 | -57.52 | -28.58 | -76.28 | -49.59 | -62.66 | -72.75 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | -0.80 | 0.00 | 0.00 | 0.00 | - |
| Net Income Before Taxes | -42.81 | -58.97 | -49.54 | -19.50 | -68.77 | -36.34 | -52.98 | -46.83 |
| Income Taxes | -2.05 | -3.54 | -6.37 | -10.55 | -11.65 | -1.62 | -7.36 | -12.62 |
| Consolidated Net Income | -40.76 | -55.43 | -43.17 | -8.95 | -57.12 | -34.73 | -45.62 | -34.21 |
| Net Income From Continuing Operations | -40.76 | -55.43 | -43.17 | -8.95 | -57.12 | -34.73 | -45.62 | -34.21 |
| Net Income | -40.76 | -55.43 | -43.17 | -8.95 | -57.12 | -34.73 | -45.62 | -34.21 |
| EPS (Recurring) per share | -0.13 | -0.18 | -0.14 | -0.03 | -0.19 | -0.12 | -0.15 | -0.12 |
| EPS (Basic, Before Extraordinaries) per share | -0.13 | -0.18 | -0.14 | -0.03 | -0.19 | -0.12 | -0.15 | -0.12 |
| EPS (Diluted) per share | -0.13 | -0.18 | -0.14 | -0.03 | -0.19 | -0.12 | -0.15 | -0.12 |
| EBITDA | -44.70 | -53.99 | -48.86 | -20.66 | -69.04 | -42.53 | -56.05 | -58.85 |
| Non-Operating Income (Expense) | 10.50+39.8% | 3.81-71.2% | 7.98-17.6% | 8.28-67.1% | 7.51-75.8% | 13.24-70.8% | 9.68-20.3% | 25.13+44.0% |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 9.22-16.0% | 9.71-13.5% | 9.49-18.8% | 10.19-15.3% | 10.98-19.0% | 11.22-20.1% | 11.68-15.1% | 12.03-7.4% |
| Price To Sales Ratio ratio | 68.38 | 36.25 | 13.35 | 13.68 | 42.56 | 31.14 | 28.72 | 30.05 |
| Gross Margin % | 19.01 | -116.86 | -4.09 | 82.34 | 19.18 | 58.68 | -55.96 | -175.27 |
| Operating Margin % | -501.13 | -1,550.05 | -691.75 | -63.72 | -851.79 | -290.24 | -1,479.57 | -1,440.69 |
| Net Margin % | -383.10 | -1,368.57 | -519.12 | -19.94 | -637.84 | -203.27 | -1,077.24 | -677.43 |
| Shares Outstanding million shares | 326.33+9.1% | 306.47+2.6% | 303.95+1.9% | 300.60+1.6% | 299.01+1.3% | 298.65+1.4% | 298.36+1.6% | 295.76+1.7% |
| Market Capitalization | 3,795.30+152.5% | 2,397.19+134.1% | 1,058.03+59.2% | 1,023.73+18.3% | 1,503.13+96.2% | 1,023.80+17.6% | 664.51-49.9% | 865.42-47.8% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 560.33-14.2% | 652.71-17.1% | 787.18-13.8% | 913.68+22.2% | 747.98+25.9% | 594.12+7769.1% | 7.55-27.7% | 10.44 |
| Short Term Receivables | 153.40+155.0% | 60.15-6.6% | 64.38-37.7% | 103.41-40.9% | 174.86-18.0% | 213.24+6401.2% | 3.28+134.3% | 1.40 |
| Inventories | 6.34 | 0.00-100.0% | 1.11-27.5% | 1.53-8.4% | 1.67 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 8.17-78.8% | 38.51+99.4% | 19.31+181.5% | 6.86+29.7% | 5.29-11.4% | 5.97+229.8% | 1.81-45.3% | 3.31 |
| Total Current Assets | 728.23-3.1% | 751.37-13.8% | 871.99-15.0% | 1,025.49+10.3% | 929.80+14.3% | 813.33+6334.6% | 12.64-16.6% | 15.16 |
| Net Property, Plant & Equipment | 428.00+25.7% | 340.43+18.3% | 287.70+32.4% | 217.25+94.6% | 111.62+522.9% | 17.92+111.3% | 8.48+34.0% | 6.33 |
| Total Investments and Advances | 95.28-17.0% | 114.80+16.0% | 98.94+34.8% | 73.42+28.6% | 57.08+196.5% | 19.25 | 0.00 | 0.00 |
| Long-Term Note Receivable | 39.40+33.1% | 29.60+112.9% | 13.90+152.7% | 5.50 | - | 0.00 | - | - |
| Intangible Assets | 86.19-4.1% | 89.92-46.5% | 168.23-6.2% | 179.31-8.6% | 196.20+33.8% | 146.65+25184.5% | 0.58 | 0.00 |
| Deferred Tax Assets | 0.00 | 0.00 | - | 5.30-28.5% | 7.41 | - | - | - |
| Other Assets | -20.15-158.5% | 34.44-27.2% | 47.34+36.7% | 34.63+110.3% | 16.47+96.3% | 8.39+371.3% | 1.78 | 0.00 |
| Total Assets | 1,356.95-0.3% | 1,360.55-8.6% | 1,488.09-3.4% | 1,540.91+16.9% | 1,318.57+31.1% | 1,005.54+4180.7% | 23.49+9.3% | 21.49 |
| Short Term Debt Incl. Current Port. of LT Debt | 5.82+26.0% | 4.62-25.0% | 6.16+10.4% | 5.58+52.9% | 3.65+324.4% | 0.86-58.7% | 2.08-17.8% | 2.53 |
| Accounts Payable | 25.23-26.6% | 34.35+34.7% | 25.51+72.0% | 14.83-0.6% | 14.92+109.3% | 7.13+176.4% | 2.58+64.3% | 1.57 |
| Income Tax Payable | - | - | - | 0.00-100.0% | 35.68-1.3% | 36.15 | - | - |
| Other Current Liabilities | 33.26-11.6% | 37.64-56.9% | 87.35-10.8% | 97.91+47.4% | 66.42+11.9% | 59.34+1731.5% | 3.24+39.1% | 2.33 |
| Total Current Liabilities | 64.31-16.1% | 76.61-35.6% | 119.01+0.6% | 118.32-2.0% | 120.68+16.6% | 103.49+1211.7% | 7.89+22.7% | 6.43 |
| Long Term Debt | 137.40+126.2% | 60.74-14.7% | 71.22-7.1% | 76.67+110.6% | 36.41+516.1% | 5.91+47.8% | 4.00+339.6% | 0.91 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 9.12-9.3% | 10.05-67.2% | 30.61-7.7% | 33.18-11.2% | 37.37+42.9% | 26.16 | - | - |
| Other Liabilities | 4.77-33.5% | 7.17-62.3% | 19.01-76.1% | 79.46-19.2% | 98.38+149.3% | 39.46+2844.8% | 1.34-47.2% | 2.54 |
| Total Liabilities | 215.59+39.5% | 154.58-35.6% | 239.86-22.0% | 307.63+5.1% | 292.84+67.3% | 175.03+1222.0% | 13.24+34.0% | 9.88 |
| Non-Equity Reserves | 174.45+16.4% | 149.89+56.3% | 95.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 7.55-0.1% | 7.56 |
| Common Equity | 966.90-8.4% | 1,056.08-8.4% | 1,152.32-6.6% | 1,233.28+20.2% | 1,025.73+23.5% | 830.51+30546.1% | 2.71-33.1% | 4.05 |
| Total Shareholders Equity | 966.90-8.4% | 1,056.08-8.4% | 1,152.32-6.6% | 1,233.28+20.2% | 1,025.73+23.5% | 830.51+8002.5% | 10.25-11.7% | 11.61 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 966.90-8.4% | 1,056.08-8.4% | 1,152.32-6.6% | 1,233.28+20.2% | 1,025.73+23.5% | 830.51+8002.5% | 10.25-11.7% | 11.61 |
| Total Liabilities & Stockholders Equity | 1,356.95-0.3% | 1,360.55-8.6% | 1,488.09-3.4% | 1,540.91+16.9% | 1,318.57+31.1% | 1,005.54+4180.7% | 23.49+9.3% | 21.49 |
| Book Value Per Share per share | 3.22-9.8% | 3.57-9.8% | 3.96-7.9% | 4.30+18.8% | 3.62+17.5% | 3.08+15300.0% | 0.02-33.3% | 0.03 |
| Tangible Book Value Per Share per share | 2.93-10.4% | 3.27-3.3% | 3.38-7.9% | 3.67+25.3% | 2.93+15.4% | 2.54+25300.0% | 0.01-66.7% | 0.03 |
| Full-Time Employees people | 562-5.7% | 596+1.7% | 586+18.4% | 495+28.2% | 386+87.4% | 206+92.5% | 107 | - |
| Price to Book Ratio ratio | 3.57 | 0.80 | 1.38 | 2.32 | 3.95 | 13.06 | 900.92 | - |
| Return on Assets % | -10.78 | -11.43 | -9.67 | 11.09 | 13.21 | 23.11 | -9.83 | - |
| Return on Equity % | -14.47 | -14.75 | -12.27 | 14.03 | 16.53 | 28.29 | -20.22 | - |
| Return on Invested Capital % | -13.26 | -14.58 | -11.97 | 12.10 | 14.45 | 14.22 | -15.51 | 2.47 |
| Quick Ratio ratio | 11.23 | 9.81 | 7.32 | 8.65 | 7.69 | 7.86 | 1.60 | 2.36 |
| Current Ratio ratio | 11.32 | 9.81 | 7.33 | 8.67 | 7.70 | 7.86 | 1.60 | 2.36 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -145.04 | -146.41 | -162.86 | -146.40-192.4% | 158.52+3.3% | 153.46+29.0% | 118.92 | -2.21-812.9% | 0.31 |
| Depreciation | 33.44 | 28.82-70.3% | 97.00+214.0% | 30.89-6.7% | 33.10+91.9% | 17.25+227.3% | 5.27+184.9% | 1.85+101.1% | 0.92 |
| Other Funds (Non Cash) | 53.07 | 56.99 | -16.85-129.9% | 56.44-2.7% | 58.03+69.6% | 34.22+161.2% | 13.10+1113.0% | 1.08+151.2% | 0.43 |
| Funds from Operations | -58.53 | -60.60 | -82.71 | -57.10-123.1% | 247.54+22.0% | 202.91+45.6% | 139.39+19259.7% | 0.72-56.6% | 1.66 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 44.10 | -70.69 | -25.84-295.3% | 13.23-55.6% | 29.83-28.4% | 41.67 | -116.70-6023.9% | 1.97+3.1% | 1.91 |
| Income Taxes Payable | 9.47 | -29.84-548.7% | 6.65-78.2% | 30.46 | -88.61 | -13.53-137.2% | 36.41 | - | - |
| Cash from Operating Activities | -14.42 | -131.30 | -108.56 | -43.88-115.8% | 277.36+13.4% | 244.58+977.9% | 22.69+743.5% | 2.69-24.6% | 3.57 |
| Capital Expenditures | -16.93 | -42.77 | -78.40 | -77.51 | -72.66 | -58.45 | -14.67 | -4.00 | -5.31 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -11.46 | -87.64 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -124.09 | 109.18-33.5% | 164.10 | -168.91 | -296.40 | -294.96 | -19.25 | 0.00 | 0.00 |
| Purchase of Investments | -726.96 | -460.27 | -784.71 | -1,079.85 | -807.03 | -322.57 | -19.25 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 602.87 | 569.45-40.0% | 948.81+4.2% | 910.94+78.4% | 510.63+1749.4% | 27.61 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.78 | 0.00 |
| Other Sources | 21.02 | 21.34-40.2% | 35.71+41.1% | 25.31+54.0% | 16.43-49.6% | 32.62+1732.6% | 1.78 | 0.00 | 0.00 |
| Cash from Investing Activities | -120.00 | 87.75-27.7% | 121.41 | -221.11 | -352.63 | -332.25 | -119.78 | -5.78 | -5.31 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 186.86 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 4.62-99.2% | 598.50+5984900.0% | 0.01-99.9% | 10.21 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 186.86 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 4.62-99.2% | 598.50+5984900.0% | 0.01-99.9% | 10.21 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 597.50 | -0.01-100.1% | 10.17 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00-100.0% | 11.59+377.0% | 2.43 | -0.95-101.1% | 85.15+47205.6% | 0.18-90.9% | 1.98 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00-100.0% | 11.59+377.0% | 2.43 | -0.95-101.1% | 85.54 | -0.21-110.4% | 2.01 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00-100.0% | 11.59+319.9% | 2.76+217.2% | 0.87-99.2% | 105.48+55415.8% | 0.19-93.5% | 2.91 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | -0.32 | -1.82 | -19.94 | -0.40 | -0.90 |
| Net Financing Active Other Cash Flow | 29.13 | 14.08+10.3% | 12.77 | -1.23 | -4.06 | -7.55 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | -6.30 | -15.65 | -0.73 | -1.23 | -4.06 | -7.55 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 215.98 | 14.08+10.3% | 12.77+23.3% | 10.36 | -1.63 | -3.89-100.6% | 683.65+359715.8% | 0.19-98.4% | 12.19 |
| Exchange Rate Effect | -0.56 | 1.10 | -2.62-544.1% | 0.59 | -9.60 | -1.43 | - | - | - |
| Net Change in Cash | 81.01 | -28.37-223.3% | 23.01 | -254.04 | -86.49 | -92.97-115.9% | 586.56 | -2.89-127.7% | 10.44 |
| Free Cash Flow | -31.35 | -174.07 | -186.95 | -120.82-158.5% | 206.70+11.1% | 186.13+1329.6% | 13.02 | -1.30 | -1.74 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - |
| Price to Free Cash Flow ratio | - | - | - | - | 15.43 | 24.45 | 833.11 | - | - |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00-100.0% | 1.96 | -2.11 | -2.02-196.2% | 2.10 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 789.42+51.6% | 565.10-2.2% | 529.73-16.0% | 560.33-14.2% | 520.67-22.1% | 578.08-16.9% | 630.27-12.8% | 652.71-17.1% |
| Short Term Receivables | 67.28-57.8% | 95.42-37.8% | 115.72-8.6% | 153.40+155.0% | 159.36+152.0% | 153.37+126.5% | 126.61+84.1% | 60.15-6.6% |
| Inventories | 7.57 | 7.58 | 7.86 | 6.34 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% |
| Other Current Assets | 11.89-21.3% | 11.12+3.9% | 11.28+39.3% | 8.17-78.8% | 15.11+31.3% | 10.70+26.0% | 8.10-62.2% | 38.51+99.4% |
| Total Current Assets | 876.16+26.0% | 679.23-8.5% | 664.60-13.1% | 728.23-3.1% | 695.14-6.4% | 742.14-3.8% | 764.98-6.0% | 751.37-13.8% |
| Net Property, Plant & Equipment | 410.05-4.1% | 416.68-1.7% | 422.81+21.8% | 428.00+25.7% | 427.36+29.0% | 424.02+33.0% | 347.10+13.4% | 340.43+18.3% |
| Total Investments and Advances | 92.21-24.7% | 93.59-24.2% | 100.10-12.1% | 95.28-17.0% | 122.40+5.2% | 123.47+13.9% | 113.87+9.6% | 114.80+16.0% |
| Intangible Assets | 86.19-1.1% | 84.34-4.2% | 85.27-4.2% | 86.19-4.1% | 87.13-13.2% | 88.07-34.0% | 89.00-46.6% | 89.92-46.5% |
| Deferred Tax Assets | - | - | - | 0.00 | - | - | - | 0.00 |
| Other Assets | 35.26 | 33.74 | 34.35 | -20.15-158.5% | -14.23-137.4% | -11.85-120.5% | -2.34-104.3% | 34.44-27.2% |
| Total Assets | 1,499.86+10.6% | 1,307.58-6.7% | 1,307.11-2.8% | 1,356.95-0.3% | 1,355.99-2.6% | 1,402.06-0.7% | 1,344.21-8.1% | 1,360.55-8.6% |
| Short Term Debt Incl. Current Port. of LT Debt | 5.69+10.1% | 5.67+15.7% | 5.87+26.5% | 5.82+26.0% | 5.17+1.0% | 4.90-12.5% | 4.64-16.1% | 4.62-25.0% |
| Accounts Payable | 13.73-56.8% | 12.11-62.2% | 20.81-36.6% | 25.23-26.6% | 31.77-8.7% | 32.04+20.5% | 32.80+21.9% | 34.35+34.7% |
| Other Current Liabilities | 51.05+60.2% | 35.41+17.7% | 20.62-45.7% | 33.26-11.6% | 31.86-19.6% | 30.09-21.2% | 37.95-47.6% | 37.64-56.9% |
| Total Current Liabilities | 70.47+2.4% | 53.19-20.6% | 47.29-37.3% | 64.31-16.1% | 68.80-13.5% | 67.02-4.8% | 75.40-28.1% | 76.61-35.6% |
| Long Term Debt | 128.13-6.5% | 129.95-5.3% | 134.31+112.5% | 137.40+126.2% | 137.05+106.8% | 137.18+106.4% | 63.21-7.2% | 60.74-14.7% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | - | - | - | 9.12-9.3% | 9.74-23.8% | 10.05-53.8% | 10.05-66.8% | 10.05-67.2% |
| Other Liabilities | 58.49+707.9% | 50.16+280.3% | 11.32-26.4% | 4.77-33.5% | 7.24-48.5% | 13.19-29.7% | 15.37-20.7% | 7.17-62.3% |
| Total Liabilities | 257.09+15.4% | 233.30+2.6% | 192.92+17.6% | 215.59+39.5% | 222.84+29.0% | 227.45+28.3% | 164.03-26.3% | 154.58-35.6% |
| Non-Equity Reserves | 180.28+6.6% | 178.25+6.4% | 176.10+12.0% | 174.45+16.4% | 169.12+19.1% | 167.53+34.9% | 157.19+42.2% | 149.89+56.3% |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 1,062.50+10.2% | 896.02-11.0% | 938.08-8.3% | 966.90-8.4% | 964.04-10.6% | 1,007.08-9.4% | 1,022.98-9.5% | 1,056.08-8.4% |
| Total Shareholders Equity | 1,062.50+10.2% | 896.02-11.0% | 938.08-8.3% | 966.90-8.4% | 964.04-10.6% | 1,007.08-9.4% | 1,022.98-9.5% | 1,056.08-8.4% |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 1,062.50+10.2% | 896.02-11.0% | 938.08-8.3% | 966.90-8.4% | 964.04-10.6% | 1,007.08-9.4% | 1,022.98-9.5% | 1,056.08-8.4% |
| Total Liabilities & Stockholders Equity | 1,499.86+10.6% | 1,307.58-6.7% | 1,307.11-2.8% | 1,356.95-0.3% | 1,355.99-2.6% | 1,402.06-0.7% | 1,344.21-8.1% | 1,360.55-8.6% |
| Book Value Per Share per share | 3.26+1.2% | 2.92-13.4% | 3.09-9.9% | 3.22-9.8% | 3.22-11.8% | 3.37-10.6% | 3.43-10.9% | 3.57-9.8% |
| Tangible Book Value Per Share per share | 2.99+2.0% | 2.65-14.0% | 2.81-10.2% | 2.93-10.4% | 2.93-11.5% | 3.08-7.2% | 3.13-4.6% | 3.27-3.3% |
| Full-Time Employees people | - | - | - | 562-5.7% | - | - | - | 596+1.7% |
| Price to Book Ratio ratio | 3.57 | 2.54 | 1.08 | 1.06 | 1.49 | 1.00 | 0.62 | 0.80 |
| Return on Assets % | -10.39 | -12.15 | -10.86 | -10.78 | -12.49 | -11.77 | -11.96 | -11.43 |
| Return on Equity % | -14.64 | -17.30 | -14.68 | -14.47 | -16.81 | -15.64 | -15.59 | -14.75 |
| Return on Invested Capital % | -3.42 | -5.40 | -4.03 | -0.81 | -5.19 | -3.03 | -4.20 | -3.06 |
| Quick Ratio ratio | 12.33 | 12.63 | 13.89 | 11.23 | 10.10 | 11.07 | 10.15 | 9.81 |
| Current Ratio ratio | 12.43 | 12.77 | 14.05 | 11.32 | 10.10 | 11.07 | 10.15 | 9.81 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -39.77 | -54.97 | -43.17 | -7.14 | -57.81 | -36.14 | -45.62 | -31.23 |
| Depreciation | 8.43+15.2% | 8.70+19.2% | 8.66+31.0% | 7.66-36.9% | 7.32-80.9% | 7.30-80.7% | 6.61-2.4% | 12.14+38.7% |
| Other Funds (Non Cash) | 9.96-36.2% | 16.78+33.4% | 14.39-15.4% | 11.94 | 15.60 | 12.58 | 17.00-11.1% | -2.28-115.8% |
| Funds from Operations | -21.38 | -29.48 | -20.12 | 12.46 | -34.90 | -16.27 | -22.02 | -21.37 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 48.05 | 55.44 | -13.40-228.1% | -45.99-400.2% | -18.40 | -16.91 | 10.46 | 15.32+1125.6% |
| Income Taxes Payable | 27.27 | -3.02 | -4.97 | -9.81-164.5% | -12.37 | -3.31 | -4.41 | 15.20+985.7% |
| Cash from Operating Activities | 26.68 | 25.96 | -33.52 | -33.54 | -53.30 | -33.18 | -11.55 | -6.05 |
| Capital Expenditures | -1.56 | -2.10 | -3.83 | -9.43 | -9.01 | -13.79 | -10.64 | -14.20 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -180.07-498.4% | 7.95 | -22.61-228.8% | 70.65+69.3% | 45.20+241.4% | -23.99-140.7% | 17.55-62.6% | 41.74 |
| Purchase of Investments | -312.57 | -140.44 | -166.41 | -107.53 | -38.49 | -142.75 | -172.47 | -140.17 |
| Sale Or Maturity of Investments | 132.50+58.3% | 148.39+24.9% | 143.80-24.3% | 178.18-2.1% | 83.69-59.8% | 118.76-49.0% | 190.03-38.0% | 181.91-29.4% |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.19-79.3% | 5.56+0.4% | 1.36+33.3% | 13.91+135.4% | 0.92-90.3% | 5.54-55.5% | 1.02-85.8% | 5.91-41.0% |
| Cash from Investing Activities | -181.45-589.1% | 11.40 | -25.08-415.9% | 75.13+124.6% | 37.10+818.3% | -32.23-162.5% | 7.94-73.5% | 33.45 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 186.86 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | -1.58 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 186.86 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | -1.58 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 11.61+55.2% | 6.33 | 7.19+20.4% | 3.99-27.2% | 7.48+1.2% | -3.33 | 5.97 | 5.48 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | -6.30 | -0.16 | -9.04 | -0.18 | -0.16 |
| Cash from Financing Activities | 198.47+2553.3% | 6.33 | 7.19+20.4% | 3.99+2.3% | 7.48+136.7% | -3.33-227.6% | 5.97+111.0% | 3.90+6.8% |
| Exchange Rate Effect | -0.37 | -0.43-155.1% | -0.04-106.8% | 0.28 | -0.56-255.6% | 0.78 | 0.59 | -2.11-299.1% |
| Net Change in Cash | 43.33 | 43.27 | -51.45-1850.0% | 45.86+57.1% | -9.28 | -67.96-375.8% | 2.94 | 29.20 |
| Free Cash Flow | 25.11 | 23.85 | -37.35 | -42.96 | -62.31 | -46.97 | -22.19 | -20.25 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| License | 1.05 | 46.92 | +4372.8% | 62.5% |
| Milestone Payments | 1.50 | 1.00 | -33.3% | 1.3% |
| Research Fees | 26.28 | 27.21 | +3.5% | 36.2% |
| Total | 28.83 | 75.13 | +160.6% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Canada | 26.20 | 64.00 | +144.3% | 85.2% |
| Consolidation, Policy | -0.07 | 0.03 | -141.8% | 0.0% |
| United States | 2.70 | 11.10 | +311.1% | 14.8% |
| Total | 28.83 | 75.13 | +160.6% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 11.45% | 29.0M | 253.6M | 6.38M |
| 2026-10-15 | 12.20% | 30.9M | 253.6M | 6.66M |
| 2026-09-30 | 12.82% | 32.5M | 253.6M | 6.82M |
| 2026-09-15 | 13.38% | 33.9M | 253.6M | 7.43M |
| 2026-08-31 | 13.70% | 34.8M | 253.6M | 7.85M |
| 2026-08-14 | 16.58% | 41.3M | 249.3M | 8.15M |
| 2026-07-31 | 20.48% | 48.3M | 236.0M | 7.59M |
| 2026-07-15 | 19.19% | 45.1M | 235.0M | 8.07M |
| 2026-06-30 | 20.66% | 48.6M | 235.0M | 7.40M |
| 2026-06-15 | 19.11% | 44.9M | 235.0M | 6.21M |
| 2026-05-29 | 20.09% | 47.1M | 234.5M | 5.71M |
| 2026-05-15 | 18.23% | 43.0M | 235.7M | 5.09M |
| 2026-04-30 | 19.00% | 44.5M | 234.0M | 4.14M |
| 2026-04-15 | 20.39% | 47.7M | 234.0M | 3.57M |
| 2026-03-31 | 21.69% | 50.4M | 232.4M | 3.98M |
| 2026-03-13 | 21.68% | 50.4M | 232.4M | 4.21M |
| 2026-02-27 | 22.08% | 51.3M | 232.4M | 4.17M |
| 2026-02-13 | 21.62% | 50.2M | 232.3M | 4.23M |
| 2026-01-30 | 21.28% | 48.9M | 229.9M | 4.39M |
| 2026-01-15 | 20.45% | 47.0M | 229.9M | 4.35M |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 3.00 | 6.90 | 10.60 | 0.00 | 17.999 | 0.00 | 0.00 | 0.987 | -0.018 | 0.001 |
| call | 4.00 | 5.90 | 9.60 | 8.70 | 13.594 | 10.00 | 0.00 | 0.960 | -0.050 | 0.001 |
| call | 5.00 | 4.90 | 8.60 | 0.00 | 10.966 | 0.00 | 0.00 | 0.950 | -0.049 | 0.002 |
| call | 6.00 | 4.00 | 6.70 | 6.00 | 6.501 | 21.00 | 0.00 | 0.938 | -0.047 | 0.002 |
| call | 7.00 | 3.00 | 5.60 | 4.35 | 5.141 | 103 | 101 | 0.923 | -0.045 | 0.002 |
| call | 8.00 | 2.05 | 4.70 | 4.05 | 4.447 | 59.00 | 0.00 | 0.904 | -0.042 | 0.003 |
| call | 9.00 | 0.90 | 4.60 | 2.68 | 5.326 | 0.00 | 0.00 | 0.876 | -0.039 | 0.003 |
| call | 10.00 | 1.20 | 3.40 | 2.53 | 4.027 | 29.00 | 0.00 | 0.830 | -0.034 | 0.004 |
| call | 11.00 | 0.75 | 1.60 | 1.50 | 1.914 | 40.00 | 0.00 | 0.652 | -0.052 | 0.006 |
| call | 12.00 | 0.45 | 0.50 | 0.50 | 0.970 | 2,508 | 31.00 | 0.442 | -0.043 | 0.007 |
| call | 13.00 | 0.20 | 0.35 | 0.25 | 1.124 | 3,222 | 162 | 0.276 | -0.041 | 0.006 |
| call | 14.00 | 0.05 | 0.25 | 0.10 | 1.274 | 1,586 | 46.00 | 0.184 | -0.037 | 0.005 |
| call | 15.00 | 0.05 | 0.15 | 0.05 | 1.430 | 1,992 | 60.00 | 0.134 | -0.034 | 0.004 |
| call | 16.00 | 0.00 | 0.10 | 0.05 | 1.299 | 2,764 | 81.00 | 0.057 | -0.016 | 0.002 |
| call | 17.00 | 0.00 | 0.10 | 0.06 | 1.486 | 748 | 0.00 | 0.051 | -0.017 | 0.002 |
| call | 18.00 | 0.00 | 0.25 | 0.05 | 1.658 | 1,115 | 50.00 | 0.047 | -0.018 | 0.002 |
| call | 19.00 | 0.00 | 0.95 | 0.03 | 1.816 | 250 | 0.00 | 0.043 | -0.018 | 0.002 |
| call | 20.00 | 0.00 | 0.25 | 0.10 | 1.768 | 271 | 0.00 | 0.041 | -0.017 | 0.002 |
| call | 21.00 | 0.00 | 1.90 | 0.07 | 2.101 | 75.00 | 0.00 | 0.039 | -0.019 | 0.001 |
| call | 22.00 | 0.00 | 1.90 | 0.05 | 2.230 | 50.00 | 0.00 | 0.037 | -0.020 | 0.001 |
| call | 23.00 | 0.00 | 1.90 | 0.11 | 2.352 | 10.00 | 0.00 | 0.035 | -0.020 | 0.001 |
| call | 24.00 | 0.00 | 0.10 | 0.19 | 2.246 | 8.00 | 0.00 | 0.034 | -0.018 | 0.001 |
| call | 25.00 | 0.00 | 0.30 | 0.00 | 2.350 | 1.00 | 0.00 | 0.033 | -0.018 | 0.001 |
| call | 26.00 | 0.00 | 1.90 | 0.00 | 2.680 | 0.00 | 0.00 | 0.032 | -0.021 | 0.001 |
| call | 27.00 | 0.00 | 1.90 | 0.00 | 2.779 | 0.00 | 0.00 | 0.031 | -0.021 | 0.001 |
| call | 28.00 | 0.00 | 1.90 | 0.10 | 2.874 | 13.00 | 0.00 | 0.030 | -0.021 | 0.001 |
| put | 3.00 | 0.00 | 0.05 | 0.00 | 4.760 | 0.00 | 0.00 | -0.013 | -0.016 | 0.001 |
| put | 4.00 | 0.00 | 1.15 | 0.00 | 5.338 | 0.00 | 0.00 | -0.040 | -0.049 | 0.001 |
| put | 5.00 | 0.00 | 1.90 | 0.00 | 4.336 | 0.00 | 0.00 | -0.050 | -0.048 | 0.002 |
| put | 6.00 | 0.00 | 0.75 | 0.05 | 3.528 | 27.00 | 0.00 | -0.062 | -0.047 | 0.002 |
| put | 7.00 | 0.00 | 1.15 | 0.05 | 2.845 | 2.00 | 0.00 | -0.077 | -0.044 | 0.002 |
| put | 8.00 | 0.00 | 1.90 | 0.10 | 2.245 | 217 | 0.00 | -0.096 | -0.042 | 0.003 |
| put | 9.00 | 0.00 | 0.75 | 0.05 | 1.702 | 181 | 2.00 | -0.124 | -0.038 | 0.003 |
| put | 10.00 | 0.00 | 0.20 | 0.10 | 1.190 | 1,062 | 11.00 | -0.170 | -0.032 | 0.004 |
| put | 11.00 | 0.15 | 0.45 | 0.30 | 1.094 | 3,744 | 34.00 | -0.348 | -0.051 | 0.006 |
| put | 12.00 | 0.35 | 0.90 | 0.70 | 1.015 | 766 | 17.00 | -0.552 | -0.044 | 0.007 |
| put | 13.00 | 1.10 | 1.80 | 1.30 | 1.346 | 638 | 0.00 | -0.724 | -0.040 | 0.006 |
| put | 14.00 | 1.05 | 3.20 | 2.95 | 2.384 | 293 | 0.00 | -0.816 | -0.035 | 0.005 |
| put | 15.00 | 2.45 | 4.30 | 3.70 | 2.896 | 13.00 | 0.00 | -0.866 | -0.032 | 0.004 |
| put | 16.00 | 2.60 | 6.20 | 4.80 | 4.591 | 0.00 | 0.00 | -0.943 | -0.014 | 0.002 |
| put | 17.00 | 3.40 | 7.30 | 5.80 | 5.035 | 4.00 | 0.00 | -0.949 | -0.015 | 0.002 |
| put | 18.00 | 4.40 | 8.20 | 0.00 | 5.154 | 0.00 | 0.00 | -0.953 | -0.016 | 0.002 |
| put | 19.00 | 5.40 | 9.20 | 0.00 | 5.399 | 0.00 | 0.00 | -0.957 | -0.016 | 0.002 |
| put | 20.00 | 6.40 | 10.10 | 0.00 | 5.473 | 0.00 | 0.00 | -0.959 | -0.017 | 0.001 |
| put | 21.00 | 7.40 | 11.10 | 0.00 | 5.681 | 0.00 | 0.00 | -0.961 | -0.017 | 0.001 |
| put | 22.00 | 8.40 | 12.10 | 0.00 | 5.876 | 0.00 | 0.00 | -0.963 | -0.017 | 0.001 |
| put | 23.00 | 9.40 | 13.10 | 0.00 | 6.058 | 0.00 | 0.00 | -0.965 | -0.017 | 0.001 |
| put | 24.00 | 10.40 | 14.10 | 0.00 | 6.229 | 0.00 | 0.00 | -0.966 | -0.018 | 0.001 |
| put | 25.00 | 11.40 | 15.10 | 0.00 | 6.390 | 0.00 | 0.00 | -0.967 | -0.018 | 0.001 |
| put | 26.00 | 12.40 | 16.10 | 0.00 | 6.542 | 0.00 | 0.00 | -0.968 | -0.018 | 0.001 |
| put | 27.00 | 13.40 | 17.10 | 0.00 | 6.687 | 0.00 | 0.00 | -0.969 | -0.018 | 0.001 |
| put | 28.00 | 14.40 | 18.10 | 0.00 | 6.824 | 0.00 | 0.00 | -0.970 | -0.018 | 0.001 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-12 | SEC |
| 2026-11-09 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-09 | 8-K | Current report | 2026-11-09 | SEC |
| 2026-08-24 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-24 | SEC |
| 2026-08-18 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-18 | SEC |
| 2026-08-14 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-14 | SEC |
| 2026-08-14 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-12 | SEC |
| 2026-08-13 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-11 | SEC |
| 2026-08-13 | 8-K | Current report | 2026-08-12 | SEC |
| 2026-08-13 | 424B5 | SEC | ||
| 2026-08-11 | 424B5 | SEC | ||
| 2026-08-10 | 8-K | Current report | 2026-08-10 | SEC |
| 2026-08-07 | 8-K | Current report | 2026-08-07 | SEC |
| 2026-08-05 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-05 | 8-K | Current report | 2026-08-05 | SEC |
| 2026-07-29 | 8-K | Current report | 2026-07-29 | SEC |
| 2026-07-06 | 8-K | Current report | 2026-06-30 | SEC |
| 2026-07-06 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-01 | SEC |
| 2026-07-06 | 3 | Initial statement of beneficial ownership of securities | 2026-06-30 | SEC |
| 2026-07-06 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-01 | SEC |
| 2026-06-17 | 8-K | Current report | 2026-06-17 | SEC |
| 2026-06-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-11 | SEC |
| 2026-06-12 | 8-K | Current report | 2026-06-11 | SEC |
| 2026-06-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-11 | SEC |
| 2026-06-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-11 | SEC |
| 2026-06-11 | 3 | Initial statement of beneficial ownership of securities | 2026-06-01 | SEC |
| 2026-06-05 | 8-K | Current report | 2026-06-01 | SEC |
| 2026-06-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-03 | SEC |
| 2026-05-18 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-14 | SEC |
| 2026-05-11 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-03-31 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 698.92K | 1 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| BAKER BROS. ADVISORS LP | 10.81% |
| Capital World Investors | 4.19% |
| TWO SIGMA INVESTMENTS, LP | 3.42% |
| TD Waterhouse Canada Inc. | 2.85% |
| BANK OF AMERICA CORP /DE/ | 2.01% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.41% |
| ArrowMark Colorado Holdings LLC | 1.34% |
| BlackRock, Inc. | 1.25% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.94% |
| TUDOR INVESTMENT CORP ET AL | 0.68% |
Funds
| Fund | % owned |
|---|---|
| SMALLCAP World Fund Inc | 4.33% |
| iShares Biotechnology ETF | 0.54% |
| BlackRock Health Sciences Opportunities Portfolio | 0.39% |
| T. Rowe Price New Horizons Fund, Inc. | 0.35% |
| Counterpoint Quantitative Equity ETF | 0.32% |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | 0.18% |
| iShares Genomics Immunology and Healthcare ETF | 0.17% |
| SMALLCAP World Fund | 0.12% |
| BlackRock Advantage Small Cap Core Fund | 0.10% |
| Driehaus Micro Cap Growth Fund | 0.08% |
OakChart. ABCL. Cached 15 minutes. Terms